175 related articles for article (PubMed ID: 21874572)
21. Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate.
Troxel SA; Sidhu H; Kaul P; Low RK
J Endourol; 2003 Apr; 17(3):173-6. PubMed ID: 12803990
[TBL] [Abstract][Full Text] [Related]
22. Effect of cinnamon and turmeric on urinary oxalate excretion, plasma lipids, and plasma glucose in healthy subjects.
Tang M; Larson-Meyer DE; Liebman M
Am J Clin Nutr; 2008 May; 87(5):1262-7. PubMed ID: 18469248
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of urinary stone disease by a multi-species bacterial network ensures healthy oxalate homeostasis.
Miller AW; Choy D; Penniston KL; Lange D
Kidney Int; 2019 Jul; 96(1):180-188. PubMed ID: 31130222
[TBL] [Abstract][Full Text] [Related]
24. A Double-Blind, Placebo Controlled, Randomized Phase 1 Cross-Over Study with ALLN-177, an Orally Administered Oxalate Degrading Enzyme.
Langman CB; Grujic D; Pease RM; Easter L; Nezzer J; Margolin A; Brettman L
Am J Nephrol; 2016; 44(2):150-8. PubMed ID: 27529510
[TBL] [Abstract][Full Text] [Related]
25. Dietary influence on serum and urinary oxalate in healthy subjects and oxalate stone formers.
Butz M; Hoffmann H; Kohlbecker G
Urol Int; 1980; 35(5):309-15. PubMed ID: 7423675
[TBL] [Abstract][Full Text] [Related]
26. Effects of calcium supplements on the risk of renal stone formation in a population with low oxalate intake.
Stitchantrakul W; Sopassathit W; Prapaipanich S; Domrongkitchaiporn S
Southeast Asian J Trop Med Public Health; 2004 Dec; 35(4):1028-33. PubMed ID: 15916110
[TBL] [Abstract][Full Text] [Related]
27. Intestinal hyperabsorption of oxalate in calcium oxalate stone formers: application of a new test with [13C2]oxalate.
Hesse A; Schneeberger W; Engfeld S; Von Unruh GE; Sauerbruch T
J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S329-33. PubMed ID: 10541257
[TBL] [Abstract][Full Text] [Related]
28. The effect of oral administration of calcium and magnesium on intestinal oxalate absorption in humans.
Voss S; Zimmermann DJ; Hesse A; von Unruh GE
Isotopes Environ Health Stud; 2004 Sep; 40(3):199-205. PubMed ID: 15370283
[TBL] [Abstract][Full Text] [Related]
29. Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration.
Campieri C; Campieri M; Bertuzzi V; Swennen E; Matteuzzi D; Stefoni S; Pirovano F; Centi C; Ulisse S; Famularo G; De Simone C
Kidney Int; 2001 Sep; 60(3):1097-105. PubMed ID: 11532105
[TBL] [Abstract][Full Text] [Related]
30. Screening of different probiotic strains for their in vitro ability to metabolise oxalates: any prospective use in humans?
Mogna L; Pane M; Nicola S; Raiteri E
J Clin Gastroenterol; 2014; 48 Suppl 1():S91-5. PubMed ID: 25291139
[TBL] [Abstract][Full Text] [Related]
31. The impact of dietary calcium and oxalate ratios on stone risk.
Lange JN; Wood KD; Mufarrij PW; Callahan MF; Easter L; Knight J; Holmes RP; Assimos DG
Urology; 2012 Jun; 79(6):1226-9. PubMed ID: 22480460
[TBL] [Abstract][Full Text] [Related]
32. Metabolic activity of probiotics-oxalate degradation.
Murphy C; Murphy S; O'Brien F; O'Donoghue M; Boileau T; Sunvold G; Reinhart G; Kiely B; Shanahan F; O'Mahony L
Vet Microbiol; 2009 Apr; 136(1-2):100-7. PubMed ID: 19028028
[TBL] [Abstract][Full Text] [Related]
33. Diet, but not oral probiotics, effectively reduces urinary oxalate excretion and calcium oxalate supersaturation.
Lieske JC; Tremaine WJ; De Simone C; O'Connor HM; Li X; Bergstralh EJ; Goldfarb DS
Kidney Int; 2010 Dec; 78(11):1178-85. PubMed ID: 20736987
[TBL] [Abstract][Full Text] [Related]
34. Urinary oxalate excretion increases with body size and decreases with increasing dietary calcium intake among healthy adults.
Lemann J; Pleuss JA; Worcester EM; Hornick L; Schrab D; Hoffmann RG
Kidney Int; 1996 Jan; 49(1):200-8. PubMed ID: 8770968
[TBL] [Abstract][Full Text] [Related]
35. The impact of dietary oxalate on kidney stone formation.
Holmes RP; Assimos DG
Urol Res; 2004 Oct; 32(5):311-6. PubMed ID: 15221245
[TBL] [Abstract][Full Text] [Related]
36. Oxalate absorption and postprandial urine supersaturation in an experimental human model of absorptive hypercalciuria.
Erickson SB; Cooper K; Broadus AE; Smith LH; Werness PG; Binder HJ; Dobbins JW
Clin Sci (Lond); 1984 Jul; 67(1):131-8. PubMed ID: 6547378
[TBL] [Abstract][Full Text] [Related]
37. Association of intestinal oxalate-degrading bacteria with recurrent calcium kidney stone formation and hyperoxaluria: a case-control study.
Tavasoli S; Alebouyeh M; Naji M; Shakiba Majd G; Shabani Nashtaei M; Broumandnia N; Basiri A
BJU Int; 2020 Jan; 125(1):133-143. PubMed ID: 31145528
[TBL] [Abstract][Full Text] [Related]
38. Intestinal oxalate absorption in patients with continent urinary diversion.
von Unruh GE; Ernst FB; Schmidt ME; Steiner G; Hesse A; Müller SC
World J Urol; 2005 Nov; 23(5):334-7. PubMed ID: 16283324
[TBL] [Abstract][Full Text] [Related]
39. Oxalate and sucralose absorption in idiopathic calcium oxalate stone formers.
Knight J; Jiang J; Wood KD; Holmes RP; Assimos DG
Urology; 2011 Aug; 78(2):475.e9-475.e13. PubMed ID: 21676449
[TBL] [Abstract][Full Text] [Related]
40. 'Enteral' hyperoxaluria. Effect of cholestyramine, calcium, neomycin, and bile acids on intestinal oxalate absorption in man.
Caspary WF; Tönissen J; Lankisch PG
Acta Hepatogastroenterol (Stuttg); 1977 Jun; 24(3):193-200. PubMed ID: 883468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
